Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Nuriel

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's diseasePrabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Acta Neuropathologica|April 10, 2024
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's diseasePrabesh Bhattarai, Tamil Iniyan Gunasekaran, Michael E Belloy, et al.
Nature Reviews. Drug Discovery|July 26, 2020
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageingStephen C Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer's diseaseVerena Haage, John F Tuddenham, Natacha Comandante-Lou, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's diseasePrabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Acta Neuropathologica|April 10, 2024
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's diseasePrabesh Bhattarai, Tamil Iniyan Gunasekaran, Michael E Belloy, et al.
Nature Reviews. Drug Discovery|July 26, 2020
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageingStephen C Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer's diseaseVerena Haage, John F Tuddenham, Natacha Comandante-Lou, et al.
Pageof 4